May Webinar: Leveraging machine learning strategies for nonlinear mixed effects model selection

1 messages 1 people Latest: May 03, 2023
Leveraging machine learning strategies for nonlinear mixed effects model selection (using pyDarwin) By Robert R. Bies, Pharm.D. Ph.D. FISoP Professor of Pharmaceutical Sciences, Member Institute for Artificial Intelligence and Data Science. University at Buffalo, Buffalo NY Wednesday, May 17, 2023 at 9 am -10 am PDT Register for free at https://attendee.gotowebinar.com/register/8634611478568290907 or see https://rosaandco.com/webinars Abstract: The application of machine learning approaches to pharmacokinetic and pharmacodynamic measurements is becoming more widespread. Most of these approaches are used to predict these measurements without providing inferential insights. This presentation focuses on the application of machine learning for nonlinear mixed effects PK model selection. It was recognized almost three decades ago that there are significant interactions between structural, statistical and covariate models that result in very different inferences with respect to model structure, covariate and random effects (Wade 1994). Classical stepwise approaches to model development are particularly susceptible to these interactions. Previous applications of a genetic algorithm-based model search strategy illustrated superiority of this approach to stepwise model evaluation based on typical model fitness considerations (Bies 2006, Sherer 2012, Sale 2015). The machine learning strategies described in this talk present an alternative means of evaluating the model search space that may provide greater insight into these interactions while optimizing the numerical characteristics of the solutions obtained. This is illustrated using the implementation of these techniques (Random Forest, Gaussian Process/Bayesian Optimization, Genetic Algorithm among others) in the open source pyDarwin software. Wade, J.R., Beal, S.L. & Sambol, N.C. Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis. Journal of Pharmacokinetics and Biopharmaceutics 22, 165-177 (1994). https://doi.org/10.1007/BF02353542 Sale M, Sherer EA. A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selection. Br J Clin Pharmacol. 2015 Jan;79(1):28-39. doi: 10.1111/bcp.12179. PMID: 23772792; PMCID: PMC4294074. Sherer EA, Sale ME, Pollock BG, Belani CP, Egorin MJ, Ivy PS, Lieberman JA, Manuck SB, Marder SR, Muldoon MF, Scher HI, Solit DB, Bies RR. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building. J Pharmacokinet Pharmacodyn. 2012 Aug;39(4):393-414. doi: 10.1007/s10928-012-9258-0. Epub 2012 Jul 6. PMID: 22767341; PMCID: PMC3400037. Bies RR, Muldoon MF, Pollock BG, Manuck S, Smith G, Sale ME. A genetic algorithm-based, hybrid machine learning approach to model selection. J Pharmacokinet Pharmacodyn. 2006 Apr;33(2):195-221. doi: 10.1007/s10928-006-9004-6. Epub 2006 Mar 28. PMID: 16565924.